ProQR’s Strategic Focus on RNA Editing for Liver Disease: Targeting PNPLA3 in the MASH Space
JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on ProQR (PRQR – Research Report) today and set a price target of $8.00.Stay ...
The Brighterside of News on MSN16h
Groundbreaking brain study links Parkinson’s disease and ADHD
Advancements in genetics and neuroimaging are unraveling how our DNA shapes the structure and function of the brain. Recent ...
Scientists Say We May Have Been Wrong About the Origin of Life
In a new peer reviewed analysis, scientists quantify amino acids before and after our “last universal common ancestor.” The ...